244 related articles for article (PubMed ID: 17275810)
41. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Hardwick JC; Van Den Brink GR; Bleuming SA; Ballester I; Van Den Brande JM; Keller JJ; Offerhaus GJ; Van Deventer SJ; Peppelenbosch MP
Gastroenterology; 2004 Jan; 126(1):111-21. PubMed ID: 14699493
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
43. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
44. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
45. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
46. Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma.
Basic-Jukic N; Radic-Antolic M; Hudolin T; Coric M; Zadro R; Pasini J; Kastelan Z; Kes P
Kidney Blood Press Res; 2009; 32(6):445-50. PubMed ID: 20016212
[TBL] [Abstract][Full Text] [Related]
47. Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis.
Garimella R; Kacena MA; Tague SE; Wang J; Horowitz MC; Anderson HC
J Histochem Cytochem; 2007 Jul; 55(7):745-52. PubMed ID: 17371937
[TBL] [Abstract][Full Text] [Related]
48. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC
Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360
[TBL] [Abstract][Full Text] [Related]
49. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
50. Bone morphogenetic protein (BMP)-7 but not BMP-2 and BMP-4 improves maintenance of primitive peripheral blood-derived hematopoietic progenitor cells (HPC) cultured in serum-free medium supplemented with early acting cytokines.
Grassinger J; Simon M; Mueller G; Drewel D; Andreesen R; Hennemann B
Cytokine; 2007 Dec; 40(3):165-71. PubMed ID: 18029192
[TBL] [Abstract][Full Text] [Related]
51. TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling.
Jin W; Yun C; Kim HS; Kim SJ
Cancer Res; 2007 Oct; 67(20):9869-77. PubMed ID: 17942918
[TBL] [Abstract][Full Text] [Related]
52. Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells.
Finkenzeller G; Hager S; Stark GB
Microvasc Res; 2012 Jul; 84(1):81-5. PubMed ID: 22487440
[TBL] [Abstract][Full Text] [Related]
53. Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
Yao K; Shida S; Selvakumaran M; Zimmerman R; Simon E; Schick J; Haas NB; Balke M; Ross H; Johnson SW; O'Dwyer PJ
Clin Cancer Res; 2005 Oct; 11(20):7264-72. PubMed ID: 16243796
[TBL] [Abstract][Full Text] [Related]
54. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.
Alarmo EL; Rauta J; Kauraniemi P; Karhu R; Kuukasjärvi T; Kallioniemi A
Genes Chromosomes Cancer; 2006 Apr; 45(4):411-9. PubMed ID: 16419056
[TBL] [Abstract][Full Text] [Related]
55. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E
FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412
[TBL] [Abstract][Full Text] [Related]
56. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
57. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.
Hartung A; Bitton-Worms K; Rechtman MM; Wenzel V; Boergermann JH; Hassel S; Henis YI; Knaus P
Mol Cell Biol; 2006 Oct; 26(20):7791-805. PubMed ID: 16923969
[TBL] [Abstract][Full Text] [Related]
58. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
59. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2.
Singhatanadgit W; Mordan N; Salih V; Olsen I
Int J Biochem Cell Biol; 2008; 40(12):2854-64. PubMed ID: 18619554
[TBL] [Abstract][Full Text] [Related]
60. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
